Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients

University of Lahore

Status: Completed

Conditions: Corona Virus Infection

Treatments: Drug: Nitroglycerin

Study type: Interventional

Funder types: Other

Identifiers

NCT04686760

IRBEC/BIH/08-2020

Details and patient eligibility

About

In current analysis moderate to severely ill Covid-19 infected patients will be nebulized with nitroglycerin, and they will be compared with the standard nebulization

Enrollment: 278 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Diagnosed admitted cases of Covid-19 degree of illness should be moderate to severe both male and female every age group

Exclusion criteria

allergic to nitroglycerin sudden drop in blood pressure not given consent

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

278 participants in 2 patient groups

Nitroglycerin solution

Experimental group

Treatment:

Drug: Nitroglycerin

standard solution

No Intervention group